Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Summary characteristics of included studies

From: Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis

Author

Country

Study design

Male numbers

Age (years)

Self-reported or health record data

Sample size

NOS score

Abara 2023 [25]

USA

Cross-sectional study

NA

≥ 15

Self-reported data

78

4

Amanda D 2022 [26]

USA

Cross-sectional study

58

≥ 18

Self-reported data

229

5

Borcak 2024 [30]

Turkey

Cross-sectional study

176

18–29 years

Self-reported data

203

5

Chow 2023 [28]

Australia

Cross-sectional study

491

> 18

Self-reported data

44

4

D. Filardo 2023 [27]

USA

Cross-sectional study.

87

46 (Median)

Self-reported data

15

5

Dukers-Muijrers 2022 [33]

Netherlands

Cross-sectional study

NA

42 (Median)

Self-reported data

225

4

Fu 2023 [21]

China

Cross-sectional study

299

< 25 to ≥ 40

Self-reported data

577

5

Karapinar 2023 [31]

Turkiye

Cross-sectional study

NA

38 (mean)

Self-reported data

155

5

M. Araoz-Salinas 2023 [24]

USA

Cross-sectional study

285

31 (mean)

Self-reported data

131

5

MacGibbon 2023 [29]

Australia

Cross-sectional study

NA

> 16 years

Self-reported data

1733

4

P. F. Chow 2023 [46]

Australia

Retrospective observational study

NA

> 16 years

Self-reported data

84

5

Reyes-Uruena 2022 [32]

United Kingdom

Cross-sectional survey

NA

> 18 years

Self-reported data

123

5

Svartstein 2023 [34]

Denmark

Observational, longitudinal study

727

55.7 (Median)

Self-reported data

246

4

Wolff Sagy 2023 [36]

Israel

Cross-sectional study

2,054

18–42

Health-reported data

511

4

Zheng 2022 [22]

China

Observational study

618

< 25 to > 45

Self-reported data

1920

6

Zheng 2023 [23]

China

Cross-sectional study

7163

≥ 16

Self-reported data

722

5

Zucman 2022 [35]

France

Cross-sectional study

252

30 to 59

Self-reported data

252

4